These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39075633)

  • 61. Statins for the primary prevention of cardiovascular disease.
    Taylor F; Huffman MD; Macedo AF; Moore TH; Burke M; Davey Smith G; Ward K; Ebrahim S
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004816. PubMed ID: 23440795
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Associations of low-density lipoprotein cholesterol with all-cause and cause-specific mortality in older adults in China.
    Ni W; Lv Y; Yuan X; Zhang Y; Zhang H; Zheng Y; Shi X; Xu J
    J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38436437
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The relationship of low-density lipoprotein cholesterol and all-cause or cardiovascular mortality in patients with type 2 diabetes: a retrospective study.
    Chang CH; Yeh ST; Ooi SW; Li CY; Chen HF
    PeerJ; 2023; 11():e14609. PubMed ID: 36643628
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease.
    Yang Q; Zou Y; Lang Y; Yang J; Wu Y; Xiao X; Qin C; Zhao Y; Liu F
    Ren Fail; 2024 Dec; 46(2):2369701. PubMed ID: 38952279
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study.
    Usui T; Nagata M; Hata J; Mukai N; Hirakawa Y; Yoshida D; Kishimoto H; Kitazono T; Kiyohara Y; Ninomiya T
    J Atheroscler Thromb; 2017 Jul; 24(7):706-715. PubMed ID: 27840387
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants.
    Kim HJ; Jeong S; Oh YH; Park SJ; Cho Y; Park SM
    Cardiovasc Diabetol; 2023 Mar; 22(1):71. PubMed ID: 36978181
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
    Schmidt AF; Pearce LS; Wilkins JT; Overington JP; Hingorani AD; Casas JP
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011748. PubMed ID: 28453187
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discordant High Remnant Cholesterol With LDL-C Increases the Risk of Stroke: A Chinese Prospective Cohort Study.
    Han M; Huang K; Shen C; Hu H; Liu F; Li J; Yang X; Chen J; Liu X; Cao J; Chen S; Yu L; Zhao Y; Wu X; Zhao L; Li Y; Hu D; Huang J; Lu X; Gu D
    Stroke; 2024 Aug; 55(8):2066-2074. PubMed ID: 39038095
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The U Shaped Relationship Between High-Density Lipoprotein Cholesterol and All-Cause or Cause-Specific Mortality in Adult Population.
    Huang YQ; Liu XC; Lo K; Liu L; Yu YL; Chen CL; Huang JY; Feng YQ; Zhang B
    Clin Interv Aging; 2020; 15():1883-1896. PubMed ID: 33061337
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dose-Response Associations of Lipid Traits With Coronary Artery Disease and Mortality.
    Yang G; Mason AM; Wood AM; Schooling CM; Burgess S
    JAMA Netw Open; 2024 Jan; 7(1):e2352572. PubMed ID: 38241044
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum fructosamine and risk of cardiovascular and all-cause mortality: a 24-year prospective population-based study.
    Zaccardi F; Kurl S; Pitocco D; Ronkainen K; Laukkanen JA
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):236-41. PubMed ID: 25445881
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study.
    Ting RZ; Yang X; Yu LW; Luk AO; Kong AP; Tong PC; So WY; Chan JC; Ma RC
    Cardiovasc Diabetol; 2010 Nov; 9():77. PubMed ID: 21092182
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
    J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Excess Apolipoprotein B and Cardiovascular Risk in Women and Men.
    Johannesen CDL; Langsted A; Nordestgaard BG; Mortensen MB
    J Am Coll Cardiol; 2024 Jun; 83(23):2262-2273. PubMed ID: 38839200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.